Can I have a hair transplant while on Mounjaro (tirzepatide) for diabetes, and what peri‑operative glucose management and medication adjustments are recommended?

Hair Transplant During Mounjaro Treatment

You can proceed with hair transplant surgery while taking Mounjaro (tirzepatide), but the medication should be continued throughout the perioperative period with specific glucose monitoring protocols in place.

Medication Management for Mounjaro

Continue tirzepatide throughout the perioperative period. The most recent 2025 multidisciplinary consensus statement explicitly recommends that patients should continue taking GLP-1 receptor agonists (which includes the GLP-1 component of tirzepatide) throughout the peri-operative period 1. While this guideline specifically addresses GLP-1RAs, tirzepatide as a dual GIP/GLP-1 agonist shares the same GLP-1 mechanism.

Critical Perioperative Considerations

The primary concern with tirzepatide is delayed gastric emptying, not glucose control. The FDA label for Mounjaro specifically warns that patients "scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)" should inform their healthcare provider 2. This is because GLP-1 agonists can cause gastroparesis and delayed gastric emptying, potentially increasing aspiration risk during anesthesia.

For your hair transplant procedure:

• Discuss aspiration risk mitigation with your anesthesiologist using shared decision-making 1
• Adhere strictly to recommended fasting guidelines (typically 8 hours for solids, 2 hours for clear liquids)
• Consider point-of-care gastric ultrasound before anesthesia if available 1
• Your anesthesia team may use modified rapid sequence intubation or other aspiration-prevention techniques 1

Glucose Management Protocol

Target perioperative blood glucose: 100-180 mg/dL (5.6-10.0 mmol/L) 3. This is the standard range for elective surgery in patients with diabetes.

Pre-operative Phase

• Check HbA1c if not done within 3 months; ideally should be <8% for elective surgery 3, 4
• Continue tirzepatide at your regular dose and schedule
• Monitor capillary blood glucose on arrival at the surgical facility 5
• If glucose >180 mg/dL (10 mmol/L), administer rapid-acting insulin correction 5

Day of Surgery

Do NOT stop tirzepatide. Unlike other diabetes medications that require perioperative adjustment:

• Metformin: Hold on day of surgery 3
• SGLT2 inhibitors: Must stop 3-4 days before surgery 3, 4
• Tirzepatide: Continue as scheduled 1

Intra-operative Monitoring

• Check blood glucose every 2-4 hours during the procedure 3
• Maintain glucose 100-180 mg/dL using short- or rapid-acting insulin as needed 3
• If procedure is brief and you're eating the same day, minimal intervention may be needed

Post-operative Management

• Resume normal eating as soon as possible 5
• Continue tirzepatide on your regular weekly schedule
• Monitor glucose levels until stable in target range 6
• If glucose >180 mg/dL, use rapid-acting insulin corrections 6

Special Warnings

Watch for these complications:

1. Hypoglycemia risk is LOW with tirzepatide alone, as it's glucose-dependent 2. However, if you're also taking insulin or sulfonylureas, hypoglycemia risk increases significantly 2

2. Severe hyperglycemia (>300 mg/dL or 16.5 mmol/L) should prompt immediate evaluation for ketoacidosis, though this is rare with tirzepatide 6

3. Gastrointestinal symptoms (nausea, vomiting) are common with tirzepatide 2 but should not be used alone to determine gastric content 1

Common Pitfalls to Avoid

• Do NOT stop tirzepatide thinking it's like other diabetes medications - the 2025 consensus specifically recommends continuation 1
• Do NOT skip your regular weekly dose just because surgery is scheduled
• Do NOT assume local anesthesia eliminates aspiration risk - discuss with your surgeon whether sedation will be used
• Do NOT ignore fasting instructions - delayed gastric emptying makes strict adherence critical

Hair Transplant-Specific Considerations

Hair transplant procedures typically use local anesthesia with or without mild sedation. This lower-risk anesthetic approach combined with the outpatient nature of the procedure makes it particularly suitable for patients on tirzepatide, as:

• Aspiration risk is lower with local anesthesia alone
• You can resume eating shortly after the procedure
• Glucose fluctuations are minimal with brief procedures 5
• The procedure doesn't involve significant surgical stress that would dramatically affect glucose control

The key is coordination: Ensure your hair transplant surgeon, anesthesiologist (if sedation is used), and endocrinologist/primary care provider are all aware you're taking Mounjaro and have agreed on the perioperative plan outlined above.